173 related articles for article (PubMed ID: 31704153)
1. Clinicopathological and prognostic significance of thyroid transcription factor-1 expression in small cell lung cancer: A systemic review and meta-analysis.
Wang Y; Wu Y; Li J; Li J; Che G
Pathol Res Pract; 2019 Dec; 215(12):152706. PubMed ID: 31704153
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic and Predictive Value of Thyroid Transcription Factor-1, CD56, P40 and Other Clinical Characteristics in Small Cell Lung Cancer Patients].
Wang X; Zhang Y; Hu M; Wang R; Liu L; Qian K; Li Y; Zhi X
Zhongguo Fei Ai Za Zhi; 2017 Aug; 20(8):522-527. PubMed ID: 28855032
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological characteristics of thyroid transcription factor 1-negative small cell lung cancers.
Iida Y; Masuda S; Nakanishi Y; Shimizu T; Nishimaki H; Takahashi M; Hikichi M; Maruoka S; Gon Y; Takahashi N; Hashimoto S
Hum Pathol; 2018 Sep; 79():127-134. PubMed ID: 29787820
[TBL] [Abstract][Full Text] [Related]
4. Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer.
Misch D; Blum T; Boch C; Weiss T; Crolow C; Griff S; Mairinger T; Bauer TT; Kollmeier J
Diagn Pathol; 2015 Apr; 10():21. PubMed ID: 25889870
[TBL] [Abstract][Full Text] [Related]
5. An integrative transcriptome analysis reveals a functional role for thyroid transcription factor-1 in small cell lung cancer.
Horie M; Miyashita N; Mattsson JSM; Mikami Y; Sandelin M; Brunnström H; Micke P; Nagase T; Saito A
J Pathol; 2018 Oct; 246(2):154-165. PubMed ID: 29876935
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma.
Oktay E; Oflazoglu U; Varol Y; Tanriverdi O; Mermur N; Arda HU; Demir L; Keskin O; Ahmadli T; Somali I; Oztop I; Meydan N
J Cancer Res Ther; 2018 Dec; 14(Supplement):S1201-S1208. PubMed ID: 30539871
[TBL] [Abstract][Full Text] [Related]
7. Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis.
Tong M; Wang J; Jiang N; Pan H; Li D
PLoS One; 2017; 12(8):e0182282. PubMed ID: 28797050
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas.
Schilsky JB; Ni A; Ahn L; Datta S; Travis WD; Kris MG; Chaft JE; Rekhtman N; Hellmann MD
Lung Cancer; 2017 Jun; 108():205-211. PubMed ID: 28625636
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort Studies.
Zhu L; Cao H; Zhang T; Shen H; Dong W; Wang L; Du J
Medicine (Baltimore); 2016 Apr; 95(17):e3528. PubMed ID: 27124062
[TBL] [Abstract][Full Text] [Related]
10. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
Zhang B; Xie Z; Li B
Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of the maximum standardized uptake value of pre-treatment primary lesions in small-cell lung cancer on 18F-FDG PET/CT: a meta-analysis.
Zhu D; Wang Y; Wang L; Chen J; Byanju S; Zhang H; Liao M
Acta Radiol; 2018 Sep; 59(9):1082-1090. PubMed ID: 29256260
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung.
Morise M; Hishida T; Takahashi A; Yoshida J; Ohe Y; Nagai K; Ishii G
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2121-30. PubMed ID: 25963795
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of metabolic parameters measured by
Chang H; Lee SJ; Lim J; Lee JS; Kim YJ; Lee WW
J Cancer Res Clin Oncol; 2019 May; 145(5):1361-1367. PubMed ID: 30900157
[TBL] [Abstract][Full Text] [Related]
15. High pretreatment neutrophil-lymphocyte ratio predicts recurrence and poor prognosis for combined small cell lung cancer.
Shao N; Cai Q
Clin Transl Oncol; 2015 Oct; 17(10):772-8. PubMed ID: 26243392
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and Clinicopathological Value of Rac1 in Cancer Survival: Evidence from a Meta-Analysis.
Lou S; Wang P; Yang J; Ma J; Liu C; Zhou M
J Cancer; 2018; 9(14):2571-2579. PubMed ID: 30026856
[No Abstract] [Full Text] [Related]
17. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
Ren W; Mi D; Yang K; Cao N; Tian J; Li Z; Ma B
Swiss Med Wkly; 2013; 143():w13855. PubMed ID: 24018850
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis.
Min SH; Zheng QQ
Medicine (Baltimore); 2021 Nov; 100(47):e27919. PubMed ID: 34964763
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment prognostic nutritional index as a prognostic factor in lung cancer: Review and meta-analysis.
Wang Z; Wang Y; Zhang X; Zhang T
Clin Chim Acta; 2018 Nov; 486():303-310. PubMed ID: 30138620
[TBL] [Abstract][Full Text] [Related]
20. Distinct Characteristics of Small Cell Lung Cancer Correlate With Central or Peripheral Origin: Subtyping Based on Location and Expression of Transcription Factor TTF-1.
Miyauchi E; Motoi N; Ono H; Ninomiya H; Ohyanagi F; Nishio M; Okumura S; Ichinose M; Ishikawa Y
Medicine (Baltimore); 2015 Dec; 94(51):e2324. PubMed ID: 26705222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
